Abstract:Dear Editor, Chronic hepatitis B virus (HBV) infection affects about 844 million people worldwide, with two million annual deaths and a rising incidence. Persistent HBV infection may lead to liver inflammation and fibrosis, a leading risk for liver transplantation and hepatocellular carcinoma.1 However, few treatment options for controlling HBV-related liver inflammation are currently available. The limited understanding on corresponding mechanisms impedes the discovery of rational therapeutics targeting on liver inflammation and fibrosis. Thus, we conducted a single-cell transcriptomic study2 to better understand the mechanisms underlying chronic HBV-related liver inflammation and to enable the discovery of therapeutic targets. Liver biopsies from six chronic HBV patients with different grades of liver inflammation were included in the present study (Figure S1; Table S1). Single-cell RNA sequencing of biopsied liver tissues was performed. Functions and cross-talks of single cells were also investigated (provided in Supplementary Materials). Based on around 24,000 single cells, we obtained 12 cell clusters. Among them, T cell population was the most abundant (Figure 1; Figure S2). By assigning the samples to different grades of inflammation (G), no apparent perturbation was observed in respect to the fractions of cells between grades G1 and G2 (Table S2). We further classified the 16, 386 T cells into nine cell subclusters, six of which varied significantly as liver inflammation progresses (Figure 2A,B). We then assigned them to known lineages based on marker genes (Figure 2C,D; Table S3). Concisely, T7 and T6 were annotated as CD8+ mucosal-associated invariant T (MAIT) cells. T2 and T0 were identified as activated and exhausted CD8+ T cells, respectively. Most interestingly, MAIT cells, especially T7, decreased, while the ratio of T6 versus T7 increased in grade G2. Moreover, T7 dominated in grade G1 (95.20%) (Figure 2E and Figure S3A,B). The above findings were confirmed by additional single-cell RNA sequencing data from liver samples of HBV-infected patients with grades G1 (n = 4) and G2 (n = 4) (Figure S3C,D).2 T6 was assumed to be developed from T7 (Figure 2F), with genes such as CCL3L1, PTMS, KLRG1 and GADD45B responsible for the transition (Figure S3E). Additionally, macrophage subcluster Ma3, inclined to have M2 signature, increased in grade G2 (Figure S4). Although no apparent perturbations were observed for the fractions of different cell types, T cell subpopulations were remodeled during the progression from grades G1 to G2. We further confirmed the presence of two MAIT cell populations by immunofluorescence, and annotated them as CD3+SLC4A10+TNFAIP3+ (T7) and CD3+SLC4A10+TNFAIP3− (T6) MAIT cells (Figure 3). T7 may have stronger direct anti-viral functions. Firstly, intrahepatic MAIT cells have been reported to be the most important innate effector cells secreting anti-viral cytokine IFN-γ,3 and T7 demonstrated up-regulated pathways ‘interferon gamma secretion’ and ‘regulation of response to interferon gamma’ (Figure 4A). Secondly, T7 may have stronger type-17 function of MAIT cell populations that might have a certain antiviral role,4 evidenced by the up-regulation of pathways such as ‘T helper 17 type immune response’. Moreover, T7 may be stronger mediators of immune responses. On one hand, T7 may increase the anti-viral capability of hepatocytes by ligand-receptor pairs such as ‘FcRn complex_ALB’ (Figure 4B), where FcRn was reported to increase the sensitivity of hepatocyte to toxicity.5 Pathways such as ‘Toll-like receptor 4 signaling pathways’ that can reduce HBV replication in an IFN-independent manner in hepatocytes6 was also up-regulated in T7. On the other hand, T7 may be more active in cytokine production and recruiting activated CD4+ and CD8+ T cells,7 evidenced by up-regulated pathways such as ‘positive regulation of CD4 positive alpha beta T cell activation’. Then, T7 may assist virus infection control via activating NK cell and CD8+ T cell mediated immune responses through cross-talks for T7-NK cells and T7-T2, evidenced by ligand-receptor pairs such as ‘HLA-C_KIR2DL3’ and ‘HLA-A_KIR3DL1’, which were reported to function as helper masters to antiviral T cell responses.8 Such results indicated that MAIT cell population T7 may have active antiviral functions for reducing HBV replication in grade G1. Immunofluorescence results for additional two biopsies obtained from two G1 patients (Figure S5) further validated the presence of T7 in grade G1. We speculated impaired antiviral roles of T6 in grade G2 from the down-regulation of corresponding pathways mentioned above, and the decrease in pathways ‘regulation of defense response to virus’ and ‘innate immune response’ (Figure 4A). Such results implied the existence of MAIT cell dysfunction in grade G2. We also observed a sharp decrease of activated CD8+ T cells, and a sharp increase of CD8+ exhausted T cells in grade G2. T cell exhaustion, in together with immune dysfunction of T6, may contribute to the inadequate HBV-specific immune responses and inadequate infection control in grade G2. The increased M2-type macrophage activation (Ma3) also implied the impaired immune response9 in grade G2. Bacterial superantigens resulting from the leaky gut of chronic HBV patients can make MAIT cells hyperactive and exhausted, which will lead to immunosuppression and increases the risk of secondary opportunistic infections.10 Thus, the dysfunction of MAIT cells T6 and exhaustion of CD8+ T cells may also provide an explanation for the progression of HBV-related inflammation in grade G2. Moreover, MAIT cells demonstrated extensive interactions with other immune cells (provided in Supplementary Materials). In conclusion, our study reported the remodelling of T cell subpopulations and the presence of two MAIT cell populations that may contribute to HBV-related liver inflammation for the first time. MAIT cell population T7 may have active roles in assisting virus clearance via direct anti-viral functions and mediating immune responses, which was impaired in T6, the proportion of which in CD8+ MAIT cells increased in grade G2. The sharp decrease of active CD8+ T cells, MAIT cell dysfunction in together may contribute to the inadequate HBV-specific immune responses in grade G2. Inspired from the decrease of MAIT cells and increased ratio of T6 versus T7 during liver inflammation progression, MAIT cells may act as a potential target for controlling HBV-related liver inflammation in future studies. However, studies using more samples are required to confirm the findings between G1 and G2 reported in this study. The present study was funded by grants from the National Natural Science Foundation of China (grant numbers: 31870839 and 81870426), the Natural Science Foundation of Zhejiang Province (grant numbers: LZ20H290002 and LY22C010001), the National Youth Top-notch Talent Support Program (grant number: W02070098), the HangZhou Medical and Health Technology Project (grant number: Z20200052), and the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (grant number: ZYYCXTD-D-202002). The authors declare that they have no conflict of interest. This work was supported by the key medical disciplines of Hangzhou and the Westlake Laboratory (Westlake Laboratory of Life Sciences and Biomedicine). The authors thank all the participants who helped collecting liver biopsies. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Proteome Responses to Stable Hepatitis B Virus Transfection and Following Interferon Alpha Treatment in Human Liver Cell Line HepG2.

Gene Expression Profiles in an Hepatitis B Virus Transfected Hepatoblastoma Cell Line and Differentially Regulated Gene Expression by Interferon-Alpha

Biopsy‐based Single‐cell Transcriptomics Reveals MAIT Cells As Potential Targets for Controlling Fibrosis‐related Liver Inflammation Due to Chronic Hepatitis‐b Infection

Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy

Liver Histopathological Features Influencing HBeAg Seroconversion in Patients with HBeAg-positive Chronic Hepatitis B Responding to Peg-IFN Treatment

Comparison of the Proteome of Huh7 Cells Transfected with Hepatitis B Virus Subgenotype A1, with or without G1862T

Hepatocytes Proteomic Alteration and Seroproteome Analysis of HBV‐transgenic Mice

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

The clinical analysis of PEG-interferon alpha-2b therapy in 61 cases of HBeAg-positive chronic hepatitis B

RNA Sequencing Analysis of Patients with Chronic Hepatitis B Treated Using PEGylated Interferon

Two-dimensional Blue Native/SDS-PAGE Analysis Reveals Heat Shock Protein Chaperone Machinery Involved in Hepatitis B Virus Production in HepG2.2.15 Cells

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

Interferon and interferon-stimulated genes in HBV treatment

Evaluation of Hepatitis B Viral Replication and Proteomic Analysis of HepG2.2.15 Cell Line after Knockdown of HBx

Pegylated Interferon Α-2B Up-Regulates Specific CD8+ T Cells in Patients with Chronic Hepatitis B.

Transfer and Expression of Human Interferon- Α Gene and Its Effect on HBV Inhibition

[HBV Transinfected Enhances the PD-L Expression of Cytokines Stimulating].

Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B

Interferon Gamma-Inducible Protein 16 of Peripheral Blood Mononuclear Cells May Sense Hepatitis B Virus Infection and Regulate the Antiviral Immunity